INSIGHTS ON QUALITY ASSURANCE

• Food Safety Digital Maturity In The Supply Chain

  Look at how connected data and automated processes strengthen safety, improve traceability, and streamline compliance across the supply chain—offering a clear roadmap for progression.

• 5 Ways GMP Manufacturers Can Start Improving Asset Performance Today

  In GMP operations, poor asset control quickly becomes a compliance risk. Learn how maintenance and calibration gaps lead to deviations and why demonstrable asset performance is essential.

• Advanced Aseptic Filling Assembly Helium Integrity Testing

  Helium leak testing offers unmatched sensitivity for detecting micro-leaks in single-use fill-finish systems. Learn how tighter leak thresholds can strengthen aseptic processing and regulatory confidence.

• A Site Bio-Decontamination Strategy: From Equipment Qualification To Process Ownership

  Pharmaceutical manufacturers can evolve beyond an OEM-developed or qualified cycle to a proactive, well-defined and controlled bio-decontamination strategy that supports a defensible validation package.

• Risk Isn't Inevitable: How The Right CDMO Protects Your Programme

  4/13/2026

  Risk in outsourced drug development is often created, not inherent. Learn how CDMO structure, continuity, and communication directly affect programme risk, timelines, and outcomes.

• Robust Database Characterizes And Optimizes Product Development

  8/29/2026

  Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

• Cell And Gene Therapy Innovations

  5/19/2025

  This interview with a pharmaceutical analytics expert discusses key insights into advances in cell and gene therapy and the strategies used to support customers in improving their therapeutic development.

• Scaling Down For Success: Optimizing Single-Use Virus Filtration For Small-Scale Bioprocessing

  9/2/2026

  Automation can bring greater consistency, product recovery, data capture, and operational efficiency to small-scale viral filtration once processes are sufficiently defined, helping gene therapy developers transition beyond highly manual workflows.

• The Shift To GMP-Compliant Automation In CGT Manufacturing

  10/6/2025

  Manual processes are yielding to automated, GMP-compliant closed systems in CGT manufacturing. This shift is crucial for meeting Annex 1 contamination standards and creating scalable, reliable commercial production.